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Introduction: Retroperitoneal neoplasms are rare and easily misdiagnosed. These tumors are often discovered
incidentally during imaging studies performed for other reasons. Paragangliomas are tumors that arise from
extra-adrenal medullary neural crest derivatives. They are usually located in the head and neck but can be found in
various body sites, including the chest cavity, abdomen, pelvis and bladder. We report the case of a patient who
had a retroperitoneal paraganglioma manifested as paralytic ileus, which is an unusual presentation of a
paraganglioma.
Case presentation: A 63-year-old Taiwanese woman was admitted to the emergency department of our hospital
with progressive abdominal fullness for two days. Her medical history included medically controlled hypertension
for 10 years and type 2 diabetes mellitus. Plain abdominal radiography showed a solitary loop of the air-filled
dilated small bowel. Abdominal computed tomography did not show a mechanical obstruction; however,
a retroperitoneal mass was incidentally detected. Histological analysis of the mass led to a diagnosis of a
paraganglioma.
Conclusions: In cases of patients with hypertension presenting with an intestinal pseudo-obstruction,
a paraganglioma may be considered as a possible differential diagnosis of retroperitoneal tumors to avoid risky
therapeutic procedures or medication that may produce severe adverse effects.Introduction
Retroperitoneal neoplasms are rare tumors and present
several therapeutic challenges because of their rarity and
relatively late presentation, with soft tissue sarcoma being
the most common type. Paragangliomas are one of these
retroperitoneal tumors that mainly affect adults who are
in the fourth or fifth decade of life, and they have no sex
predilection. Approximately 10% of patients with a para-
ganglioma have a significant family history and one-third
of cases are associated with germ line mutations in at least
nine genes (NF1, RET, SDHA, SDHB, SDHC, SDHD,
TMEM127,MAX and VHL) [1].
Most paragangliomas are located in the head and neck
and less than 5% of these tumors are endocrinologically
active [2,3]. Except for the paragangliomas that originate
from the organ of Zuckerkandl and produce various* Correspondence: mky378@ms1.mmh.org.tw
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reproduction in any medium, provided the orcatecholamines, functional paragangliomas in various
body sites secrete only noradrenaline owing to a lack of
phenylethanolamine N-methyltransferase in those areas.
Most paragangliomas with catecholamine hypersecretion
are localized to the abdomen and pelvis [2]. Patients
with secretory tumors experience paroxysmal episodic
hypertension, as well as the typical triad of symptoms
associated with pheochromocytomas, for example, palpi-
tations, headache and sweating. Nonfunctional paragan-
gliomas most commonly manifest as abdominal pain or
a mass [4]. In this report, we present a rare case of a
retroperitoneal paraganglioma that manifested as para-
lytic ileus.Case presentation
A 63-year-old Taiwanese woman was admitted to our
emergency department because she experienced pro-
gressive abdominal fullness, nausea and intermittent dull
epigastric pain for two days. Relieving or aggravating fac-
tors were not present. Her past medical history included
well controlled hypertension for 10 years; type 2 diabetes. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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eration performed 10 years ago. Her blood pressure was
177/100mmHg and heart rate was 86 beats/minute on ar-
rival at our hospital. Her abdomen was mildly distended
and tympanic with periumbilical tenderness on palpation.
Bowel sounds were hypoactive and the remaining
examination yielded normal results. Laboratory investiga-
tions showed leukocytosis (white blood cell count: 16,500
cells/uL) and unremarkable amylase and lipase values.
Carcinoembryonic antigen and cancer antigen 19–9 levels
were within normal limits.
A plain radiograph showed a coiled-spring appear-
ance of her small bowel in the left upper quadrant
(Figure 1). Ultrasonography showed a mixed-echoic lesion
(diameter approximately 4cm) near the pancreatic body
(Figure 2). A computed tomography (CT) scan of her ab-
domen incidentally showed a hypervascular retroperiton-
eal mass that had central areas of low attenuation, caused
displacement of the anterior aspect of the pancreatic body,
and was in proximity to the caudate lobe of her liver
(Figure 3).
Our patient received surgical treatment after full
fasting and adequate hydration. At the time of surgery, a
well-demarcated, hypervascular, fragile mass (approxi-
mately 6.5cm×6.5cm×4cm) was observed in her retro-
peritoneal area and was subsequently excised (Figure 4).
Pathological analysis of the mass showed that it was aFigure 1 Plain film findings. A solitary dilated loop of small bowel
was in the left upper quadrant (arrow).capsulated tumor with central necrosis and hemorrhage;
the tumor cells were arranged in sheets, large nests and
organoid patterns, and contained abundant oncocytic
cytoplasm and pleomorphic nuclei (Figure 5). The positive
results of immunohistochemical staining for chromo-
granin A, cluster of differentiation 56 and vimentin
were consistent with the presentation of a paragan-
glioma. Urinary fractionated catecholamine levels and
fractionated plasma metanephrine levels were within
normal limits and our patient recovered uneventfully
after surgery.Discussion
Pheochromocytomas and extra-adrenal paragangliomas
are very rare tumors that arise from the neural crest tissue.
These tumors are functional in more than half of such
cases, and patients commonly present with symptoms,
such as palpitation, headache, sweating and hypertension,
that are related to excess catecholamine secretion [2]. The
typical gastrointestinal manifestations include nausea,
vomiting, constipation and abdominal pain. Standard
internal medicine textbooks do not include paraganglio-
mas in the differential diagnosis of ileus; however, in sev-
eral case reports, patients with pheochromocytomas have
been found to present with ileus. Our patient received
triple-antihypertensive drug combination therapy, that is,
therapy with calcium channel blockers, angiotensin II re-
ceptor blockers and beta-blockers, for hypertension. She
presented with paralytic ileus, and there was no hyperten-
sive crisis or palpitation during admission. The ileus
improved after full fasting, adequate hydration and
tumor resection.
Intestinal pseudo-obstruction is a rare complica-
tion of these tumors. The underlying mechanism is
catecholamine-induced relaxation of the intestinal smooth
muscles, which is mainly effected by the activation of
alpha-adrenergic receptors, thereby inhibiting the release
of acetylcholine from the postganglionic nerve terminals.
Subsequently, the net effect is the depression of peristalsis
and constriction of the sphincters, thereby inducing ileus.
The other underlying mechanism involves catecholamine-
induced vasoconstriction of the mesenteric vessels. The
results of a literature review showed that ileus is related to
large tumors and high catecholamine levels [5]. In several
case reports of patients with pheochromocytomas that
manifested as ileus [5-8], the severity of the hypertensive
crisis was less in the patients with a history of hyperten-
sion than in those without a history of hypertension. In
these studies, the ileus improved after resection of the
tumor or administration of an alpha-adrenergic antagon-
ist. Other than serum catecholamines, opioid-like peptides
that are secreted by pheochromocytomas [9] may play a
role in the development of ileus.
Figure 2 Ultrasonography findings. A mix-echoic lesion was near the pancreas.
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in cases of decreased gastrointestinal myoelectric activity
and motility. However, metoclopramide worsens the symp-
toms of pseudo-obstruction owing to its catecholamine-
stimulating effect, subsequently inducing a hypertension
crisis. Therefore, metoclopramide is contraindicated in
patients with a suspected pheochromocytoma or paragan-
glioma. The initial management of paralytic ileus caused by
a paraganglioma involves providing the patient with ad-
equate alpha-blockers and hydration [7].Figure 3 Computed tomography findings. A mass was between the duSeveral radiologic imaging and nuclear imaging techni-
ques are currently available for evaluating extra-adrenal
paragangliomas. On CT images, a retroperitoneal para-
ganglioma appears as a hypervascular mass. A high rate of
preoperative CT misdiagnosis (17 out of 19, 89%) was
reported in a 2010 study [10] involving the retrospective
analysis of 19 patients who were pathologically diagnosed
with retroperitoneal paragangliomas. Magnetic resonance
imaging (MRI) is more sensitive than CT in detecting
extra-adrenal tumors. Metaiodobenzylguanidine (MIBG)odenum (D) and liver (L).
Figure 4 Intra-operative photograph. A well-demarcated mass was in the peritoneal cavity.
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and nonfunctioning paragangliomas; however, its sensitiv-
ity is quite low when compared with that of CT and MRI
[3,11]. Somatostatin receptor scintigraphy is found to be
more sensitive than MIBG scintigraphy in patients with
highly suspected head and neck paragangliomas [11].
Besides the use of imaging studies for diagnosing para-
gangliomas, assessment of the plasma normetanephrine
level or of the metanephrine and catecholamine levels
via 24-hour urine collection can help physicians make
the actual diagnosis. In our patient’s case, diagnosing the
paraganglioma before surgery was challenging; further-
more, we did not analyze the relevant serum marker.
Complete surgical excision is the treatment of choice for
extra-adrenal paragangliomas as well as for recurrent orFigure 5 Pathology findings. (a) Central necrosis and hemorrhage was n
tumor cells contained abundant oncocytic cytoplasm and pleomorphic nu
(hematoxylin and eosin × 40).metastatic neoplasms. Urinary fractionated catechol-
amine and metanephrine levels or plasma-fractionated
metanephrine levels should be measured after surgery to
evaluate residual tumor or occult metastasis. Follow-up
imaging is necessary in cases of patients with elevated
metanephrine and catecholamine levels or with nonfunc-
tional original tumors [2]. Close, lifelong follow-up is ne-
cessary and critical in the aforementioned conditions [12].
Conclusions
Preoperative diagnosis of retroperitoneal neoplasms is
difficult. Paragangliomas are very rare entities with a
limited number of cases reported, and paralytic ileus is a
rare manifestation of a paraganglioma. In cases of
patients with hypertension presenting with an intestinaloted in this capsulated tumor (hematoxylin and eosin × 5). (b) The
clei and were arranged in sheets, large nests and organoid patterns
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http://www.jmedicalcasereports.com/content/6/1/158pseudo-obstruction, a paraganglioma may be considered
as a possible differential diagnosis of a retroperitoneal
tumor. Prokinetic agents could worsen the ileus and cause
malignant hypertension. Surgical resection is necessary for
histological assessment and remains the mainstay of para-
ganglioma treatment.
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